Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
I am an active husband, father, lawyer (more than 24 years, how time flies), and investor. I believe in contrarian investing, i.e., going where the crowd isn't. I believe that successful investing, like successful living, requires equal parts listening and evaluating, followed by independent decision making.
Red Acre applies value investing principles to mirco-cap and binary event investing.
Our Chief Investment Officer is Rajesh Patel. Prior to Red Acre, Rajesh was a Member of Technical Staff with the Massachusetts Institute of Technology, (MIT) Lincoln Laboratory where he analyzed the strategic value of emerging technologies to enhance the capabilities of the U.S. Military. Rajesh holds a Ph.D. in Applied Physics from the University of California, Davis, a Master's in Environmental Science from Rice University and bachelors degrees in both Physics and English from the University of Connecticut.
Red Acre's investment style is to look for opportunities where the intrinsic value of a stock is likely to go through a dramatic transition due to some future event about which we can predict an outcome relying on our research and due diligence experience. We are patient investors and are comfortable with having time horizons of several months to over a year for our investment thesis to fully play out.
Mr. Rosenman has nearly 15-years executive experience in the health and wellness sectors, including weight loss, cosmetics skincare and nutrition, both Rx and OTC. Expertise areas include strategic market and product planning and corporate development (evaluation, recommendation and execution of strategic alliances and acquisitions). A MBA graduate of the Sweigart School of Business at Rider University, Rosenman devotes a portion of time back to the collegiate community as a graduate-level adjunct professor for healthcare marketing, consumer behavior and strategic planning. He has several published works in the field of U.S health and wellness, including a focus on how nutritional ingredients will transition into Rx space, specifically with lipid and herbal managment. His current professional role is with one of the fastest growing nutritional companies in the U.S., which also produces Rx and OTC products. He has served as an advisory board member to various organizations in the healthcare field, from venture start-ups to top global enterprises. Mr. Rosenman is a Senior Advisor with Guidepoint Global and is called upon by large institutional investors for insight and expert opinion on healthcare market opportunities (to date he has advised on more than $2 billion USD of related transactions/funding).
MarketScanners is a newsletter featuring Market Scans and Trading Ideas based on many different types of fundamentals scans, market analytics and technical analysis. Coupled with fundamentals and news catalysts, some of the plays we highlight for investors tend to move quickly and make great candidates for momentum traders and others seeking quick picks based on solid analysis and research.
Some companies featured in our newsletter pay MarketScanners for research, analysis, articles and distribution. Our reports contain forward-looking statements relating to the developments of the featured company’s products, services, future operating results and the future of the market. Statements contained in writing or in interviews are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected.
Since we are often compensated in shares or cash for our services, investors should evaluate the information on the Site with that in mind and should always perform their own independent analysis.
I'm an individual investor looking for interesting investing ideas.
I've been following the stock markets for more than 15 years.
I choose to analyze companies/stocks based on fundamentals, keeping in mind that the timing of the investment is also a crucial part for its success.
Since I am a Ph.D. psychologist, I tend to do a lot of research and bring a psychological slant to the analysis. I have a successful investing track record, including twice using very big bets on biotech stocks to radically alter my net worth for the better.
KLLJ is a private investor focusing on small cap stocks in biotechnology, emerging markets and renewable energy. I have been an active investor for 15 years and focus on picking stocks with tremendous upside. I enjoy sharing my thoughts in forums such as Seeking Alpha to help with my own due diligence process. I'm a critical thinker who appreciated constructive feedback to my investing ideas. I am not a short-term or momentum trader and like to think my strength is in picking good stocks with 10X potential returns. I don't believe in relying on Wall Street coverage of companies because of the inherent conflicts of interest (known or unknown.) We are in the market to make money and it is up to you, the individual retail investor to perform your own analysis for investment decisions if you want to win in the market. My analysis and viewpoints are not investment advice and you should always perform your own due diligence.
StockMatusow.com Writers are:
Scott Matusow; Team Leader, owner and founder of StockMatusow.com.
Scott is an independent investor/writer/trader and team leader of StockMatusow.com.
He has have about fifteen years of stock market experience which include trading, investing, and managing his family’s trust as well as his personal account.
Scott has had the most success in trading/investing in smaller cap growth companies. Because Scott is not 'officially trained' in the markets, he see things 'outside the box.' Scott uses his ability to read situations and emotion, charts, times and sales, historical data, and macroeconomic and other market forces to predict stock price movements. Using these allowed for him to completely divest his own and family's money near the top of the market before the 2008 financial crisis.
Scott has his own online talk show which can be heard at www.scottmatusow.com/radio .
During market hours, we engage in talk about Stocks and Politics. After hours, Scott engages in a variety of talk issues from Poker, Sports, Politics, Current Events and whatever the chat room people wish to talk about.
Other places you can follow Scott are:
Kyle Dennis; writer, analyst, trader, website design, and team member of Stockmatusow.com.
Kyle has a Biology degree from the University of California Los Angeles (UCLA) and specializes in trading the biotechnology sector.
Kyle has extensive experience in researching, writing, and editing articles that have been published in scientific journals. He uses these experiences to write and comment about the potential of various biotechnology companies. Kyle specializes in evaluating trial success, drug potential, and market valuations.
As an investor/trader, Kyle likes to focus on chart analysis and investor/trader sentiment to identify good entry and exit points.
Kyle can also be followed at www.twitter.com/kylewdennis @kylewdennis
Michael Kovar; writer, editor, investor, trader and team member of stockmatusow.com
Michael has spent over ten years in financial roles with companies large and small. Recently, he spent time in a consulting role with Thomson Reuters legal headquarters in Eagan, MN. He currently works in an analyst position with a healthcare organization. Since 2011, Michael has worked with Scott Matusow to help research and edit articles for Stockmatusow.com.
Michael can be followed at www.twitter.com/MMK_3399 @MMK_3399
VFC is just a guy with an opinion. VFC's Stock House brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - the biotech, pharmaceutical and healthcare sectors. VFC's Stock House provides research, informational and opinion-based coverage of various companies and stocks in multiple sectors.
The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies. Do not Buy/Sell based solely on VFC's ideas or opinions.
The goal of VFC's Stock House is to 'call it like I see it' - while bringing new ideas, companies, and discussions to the eyes of investors and readers. This is supposed to be fun and new investors should not invest with the idea that this will 'pay the bills' or with the belief that a stock will just keep going up. DD is paramount, but so is sticking to pre-conceived entry and exit strategies and not letting emotional trading get in the way.
Goals must be realistic, if it sounds far fetched, then it probably is. Let the big boys eat the cake - the small investor is just trying to pick up some crumbs, and there's nothing wrong with that!
My name is Vivian Lewis. I was born to immigrant German Jewish refugee parents in New York, so I started out as a multilingual baby and won the American Association of Teachers of French prize for high school grads in my year. I went on to study European history, first at Harvard, where I was elected to Phi Beta Kappa and from which I graduated magna cum laude, and then at University of California, Berkeley where I got an master's degree. I married Paul Lewis, a financial journalist then with the Financial Times (of London), and moved to Brussels where I pursued my PhD at the University of London. When my money ran out, I went to work for McGraw-Hill World News Common Market Bureau and never looked back. Journalism turned out to be my forte, not academia. I then went to work for The Economist in Paris followed by The Sunday Times (London).
When we lived in Washington, I took a break from journalism and worked for the Joint Economic Committee and the Senate Foreign Relations Committee. Then we returned to Europe, again living in Paris, where I was freelancing as an economic journalist. In this role I covered a half dozen countries in Europe.
We then moved back in the U.S. again, this time back to New York where my husband became U.N. Bureau Chief for The New York Times. I found it hard to get freelance work because my background was mainly European.
So in 1990 I started Global Investing, initially a print newsletter - now it's a blog. We started out covering the expanding market for American Depositary Receipts and Yankee bonds, adding open-end and later exchange-traded funds with an international bent later. Because there were so many ideas you could only buy directly on foreign markets, in 1996 I decided to start what later became Global Investing Pro, for institutional and high-net-worth investors, but it is now dormant.
My husband and I are grandparents to five.
Visit Global Investing at www.global-investing.com.
Market Folly is your go-to source for all the latest activity from prominent hedge funds. We're pleased to announce our brand new quarterly newsletter, Hedge Fund Wisdom. In it, you'll see what the hedge funds have been buying and selling. We track 25 of the most prominent managers in the game as well as provide in-depth equity analysis of the stocks they've been buying. Click the link below to see a free sample issue.
The author of Market Folly has experience at a long/short equity hedge fund, has been investing for a decade, and has degrees in Economics and Communications.
A native of Argentina, Marquez has more than 20 years’ experience as an investment banker, and is a recognized expert on both banking and investing strategies, as well as on the emerging markets of Latin America. He is also recognized as one of the investment industry’s most-talented research analysts. It was two stunning and well-publicized predictions he made in 1994 – in Argentina and in Mexico - while serving as a vice president of the Merrill Lynch Emerging Markets Fixed Income Group – that cemented Marquez’s reputation as one of Wall Street’s foremost experts on emerging-markets finance. Both countries had major currency crises by the end of that year. During his 25-year career, Marquez has held positions in such well-known financial firms as Touche Ross & Co., Barclay’s Bank, Swiss Bank, First National Bank of Boston and ADP Capital Management. He has also worked as a consultant, and as an institutional investment manager. These experiences have allowed Marquez to develop and then refine a financial-analysis approach that has enabled him to repeatedly predict major market reversals, while also identifying top investment opportunities in both stocks and bonds. Marquez earned his undergraduate degree in Business Administration, and a Master’s Degree in Industrial Administration from Carnegie-Mellon University. He currently lives in Princeton.
Disclaimer: Money Morning and Stansberry & Associates Investment Research are separate companies, and entirely distinct. Their only common thread is a shared parent company, Agora Inc. Agora Inc. was named in the suit by the SEC and was exonerated by the court, and thus dropped from the case. Stansberry & Associates was found civilly liable for a matter that dealt with one writer’s report on a company. The action was not a criminal matter. The case is still on appeal, and no final decision has been made.
Andrew Mickey is the Chief Investment Strategist of Q1 Publishing (http://www.q1publishing.com/). He has quickly emerged one of the world’s leading publishers of investment ideas and recommendations. Never one to get caught up in the herd, he has made his mark finding investment opportunities long before the rest of the pack catches on. Andrew, a contrarian to the core, has made extremely successful calls on coal, gold, silver, oil, potash, and technology stocks resulting in triple-digit gains for his readers. He is best known for urging investors to get out of ethanol stocks and buy fertilizer stocks during the height of the ethanol boom in July of 2006. His expertise and investing acumen his highly sought after. He currently sits on the advisory boards of two venture capital firms that have jointly controlled almost half a billion dollars in assets. Contact Andrew at amickey[at]q1publishing[dot]com.